Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ataciguat in Moderate Calcific Aortic Valve Stenosis
NCT02481258Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2015
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in calcific aortic valve stenosis (CAVS) comparing Ataciguat with Placebo (2 arms). Primary endpoint: Changes in Aortic Valve Calcium Levels at 6 months. Started Jun 2015; status: completed.
02
Drugs
ataciguat
03
Conditions
calcific aortic valve stenosis (CAVS)
Beyond the preview
Go deeper on NCT02481258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02481258.